Pharmacological inhibition of dihydroorotate dehydrogenase (DHODH), a crucial enzyme in this pathway, through the use of brequinar markedly reduced the viability of SCLC cells in vitro and suppressed tumor growth in vivo. The gene discussed is DHODH; the disease is small cell lung carcinoma.